Yifeng Xia
215123, PR China
Puerto Rico
Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum to "Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia" [Bioact. Mater. 21 (March 2023) 499-510].
Journal: Bioactive materials
Published: August 02, 2023
Correction to "CD38-Directed Vincristine Nanotherapy for Acute Lymphoblastic Leukemia".
Journal: Biomacromolecules
Published: June 27, 2022
Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia.
Journal: Bioactive materials
Published: March 08, 2022
Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy.
Journal: Bioactive materials
Published: October 28, 2021
Systemic administration of polymersomal oncolytic peptide LTX-315 combining with CpG adjuvant and anti-PD-1 antibody boosts immunotherapy of melanoma.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 28, 2021
A6 peptide-tagged, ultra-small and reduction-sensitive polymersomal vincristine sulfate as a smart and specific treatment for CD44+ acute myeloid leukemia.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 10, 2020
GE11 peptide-installed chimaeric polymersomes tailor-made for high-efficiency EGFR-targeted protein therapy of orthotopic hepatocellular carcinoma.
Journal: Acta biomaterialia
Published: March 23, 2020
Lung cancer specific and reduction-responsive chimaeric polymersomes for highly efficient loading of pemetrexed and targeted suppression of lung tumor in vivo.
Journal: Acta biomaterialia
Published: November 11, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026